Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.

Navarro-Cecilia J, Dueñas-Rodríguez BLuque-López C, Ramírez-Expósito MJMartínez-Ferrol J, Ruíz-Mateas AUreña C, Carrera-González MPMayas MD, Martínez-Martos JM2024-02-262024-02-262013-08Navarro-Cecilia J, Dueñas-Rodríguez B, Luque-López C, Ramírez-Expósito MJ, Martínez-Ferrol J, Ruíz-Mateas A, Ureña C, Carrera-González MP, Mayas MD, Martínez-Martos JM. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy. Eur J Surg Oncol. 2013 Aug;39(8):873-9.DOI: 10.1016/j.ejso.2013.05.002https://hdl.handle.net/10953/2460Atribución-NoComercial-SinDerivadas 3.0 Españahttp://creativecommons.org/licenses/by-nc-nd/3.0/es/Breast cancer.LymphadenectomyNeoadjuvant chemotherapyOSNASentinel nodeIntraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.info:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccess